Clinical Trials Logo

Clinical Trial Summary

Microperimetry is a relatively new and extremely sensitive method of assessing visual function. It projects light stimuli onto a defined area of the retina to map retinal perceptual thresholds. Participants look at a focal point and press a button to indicate when they have seen a light stimulus. The stimuli vary in intensity to find the participant's visual sensitivity.

Microperimetry is carried out in low light conditions. Before testing, participants must adapt to the low light conditions in a process called 'dark adaptation.' Currently there is no consensus on the optimal time needed for dark adaptation. Investigators know that visual sensitivity differs in differing light conditions. Failing to sufficiently dark-adapt may therefore adversely affect test results.

The aim of this study is to establish the optimal length of dark adaptation for microperimetry performance in healthy volunteers. On day 1, participants will undergo training field tests to reduce a learning effect affecting the results. Tests will then be performed following 5 mins adaptation, 10 mins adaptation and 30mins adaptation, On day 2, participants will perform testing following no adaptation time, 15 mins adaptation, and 20 mins adaptation. Statistics will be used to determine the effect of adaptation time on average threshold measures.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02729818
Study type Observational
Source University of Oxford
Contact
Status Completed
Phase
Start date February 2016
Completion date September 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05597397 - Effect of Repeated Low-Level Red-Light Therapy on Retinal Function and Structure N/A
Recruiting NCT05288192 - Changes After Suprachoroidal Injection. N/A
Completed NCT05801419 - Nicotine Influence on the Retina Following the Use of Electronic Cigarette N/A
Recruiting NCT05082402 - Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease N/A